Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Recruiting now

Conditions studied: Bone Metastases

In brief

From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022. A review will be made from the medical records, radiological imaging, and histological data of these patients

Key facts

Study ID

NCT06524843

Run by

Costantino Errani

People needed

250

Starts

2024-09-23

Expected to finish

2026-12-01

Last updated by the study team

2025-12-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
• Availability of imaging and clinical data
• Availability of at least one follow-up during the last 12 months form diagnosis

You may not qualify if…

• At least one inclusion creteria not met

Where it is running

• IRCCS Istituto Ortopedico Rizzoli — Bologna, Emilia-Romagna, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.